MD vs ADUS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

MD

35.0
AI Score
VS
ADUS Wins

ADUS

44.9
AI Score

Investment Advisor Scores

MD

35score
Recommendation
SELL

ADUS

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MD ADUS Winner
Net Income 95.91M 69.42M ADUS
Operating Income 138.62M 98.58M ADUS
ROE 8.8% 7.9% ADUS
ROA 6.7% 3.3% ADUS
Total Assets 1.44B 2.13B MD
Cash 81.62M 288.88M MD
Debt/Equity 0.11 0.69 ADUS
Current Ratio 1.80 1.32 ADUS

Relative Price Performance (Last 90 Days)

MD 1M: +14.3% · 3M: +12.5% ADUS 1M: +6.7% · 3M: +7.1%

Current Technical Phase

MD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 75

RSI (14): 74.7 · Price: $29.55

ADUS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 70

RSI (14): 70.3 · Price: $122.67

Fundamentals Snapshot

Metric MD ADUS
Market Cap — —
Forward P/E 12.1 16.3
Trailing P/E 13.4 20.7
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin 0.3% 0.3%
Operating Margin 0.1% 0.1%
EPS 2.09 5.70
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ADUS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.